Filtered Listing Testing

Learn about 32 new Alzheimer's disease research grants totaling over $6.8 million, a clinical trial that aims to slow memory loss before Alzheimer's symptoms appear, the association between weight and Alzheimer's, and a "cocktail" approach of treating Alzheimer's, in the fall 2016 edition of the Alzheimer's Disease Research Review.

You can have a direct impact on fighting Alzheimer’s through science. How? By joining the community of Stall Catchers – the first online game to crowdsource Alzheimer’s disease (AD) research.

The world’s leading corporations, NGO’s, and public sector organizations, convened to innovate and collaborate at the 2016 Ideagen Global Good Summit.

The Alliance for Aging Research, in partnership with BrightFocus Foundation, has launched an educational awareness campaign aimed at getting older adults and their caregivers to “Take a Closer Look at Age-Related Macular Degeneration.

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.

Jeffrey Goldberg, MD, PhD, a BrightFocus grantee answers questions about an exciting new clinical trial for glaucoma.

BrightFocus Foundation, a nonprofit supporting research worldwide on diseases of mind and sight, has named Nancy Lynn as Senior Vice President, Strategic Partnerships.

BrightFocus Foundation, a leading private funder of research on diseases of mind and sight, has named Diane Bovenkamp, PhD, as its new Vice President, Scientific Affairs.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

The discoveries of Nobel laureate Yoshinori Ohsumi are helping us fight Alzheimer’s, AMD, and glaucoma. Their impact is explained by a BrightFocus grantee.